X0306 4 2015-03-16 0000880771 SCICLONE PHARMACEUTICALS INC SCLN 0001363213 Blobel Friedhelm 950 TOWER LANE, SUITE 900 FOSTER CITY CA 94404 0 1 0 0 President & CEO Stock Option (right to buy) 8.83 2015-03-16 4 A 0 140000 0 A 2025-03-16 Common Stock 140000 140000 D Restricted Stock Unit 2015-03-16 4 A 0 20000 0 A Common Stock 20000 104017 D Granted under the Issuer's 2005 Equity Incentive Plan. 25% of such shares vest from the date of grant and 2.0833% vests each month thereafter, provided that the Reporting Person continues to be employed by the Issuer. Each restricted stock unit represents the right to receive, at settlement, one share of common stock. Vesting for such RSUs will occur 25% on March 16, 2016, 25% on March 16, 2017, 25% on March 16, 2018, and 25% on March 16, 2019, or on such later date thereafter as the Company's trading window opens, if it is not open on any of such dates, contingent upon the executive's continued employment. /s/ Friedhelm Blobel, Ph.D. 2015-03-18